DK1067935T3 - Acylbenzoxaziner til forstærkning af synaptisk(e) reaktion(er) - Google Patents
Acylbenzoxaziner til forstærkning af synaptisk(e) reaktion(er)Info
- Publication number
- DK1067935T3 DK1067935T3 DK99915240T DK99915240T DK1067935T3 DK 1067935 T3 DK1067935 T3 DK 1067935T3 DK 99915240 T DK99915240 T DK 99915240T DK 99915240 T DK99915240 T DK 99915240T DK 1067935 T3 DK1067935 T3 DK 1067935T3
- Authority
- DK
- Denmark
- Prior art keywords
- ampa receptors
- treatment
- methods
- acylbenzoxazines
- impaired
- Prior art date
Links
- 230000009782 synaptic response Effects 0.000 title abstract 2
- 102000003678 AMPA Receptors Human genes 0.000 abstract 3
- 108090000078 AMPA Receptors Proteins 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000002708 enhancing effect Effects 0.000 abstract 2
- 230000001771 impaired effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- YXTROGRGRSPWKL-UHFFFAOYSA-N 1-benzoylpiperidine Chemical class C=1C=CC=CC=1C(=O)N1CCCCC1 YXTROGRGRSPWKL-UHFFFAOYSA-N 0.000 abstract 1
- CMLFRMDBDNHMRA-UHFFFAOYSA-N 2h-1,2-benzoxazine Chemical group C1=CC=C2C=CNOC2=C1 CMLFRMDBDNHMRA-UHFFFAOYSA-N 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 230000036992 cognitive tasks Effects 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 230000002964 excitative effect Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 210000000225 synapse Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/054,916 US6124278A (en) | 1998-04-03 | 1998-04-03 | Acylbenzoxazines for enhancing synaptic response |
| PCT/US1999/007325 WO1999051240A1 (en) | 1998-04-03 | 1999-04-02 | Acylbenzoxazines for enhancing synaptic response(s) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1067935T3 true DK1067935T3 (da) | 2003-11-24 |
Family
ID=21994357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99915240T DK1067935T3 (da) | 1998-04-03 | 1999-04-02 | Acylbenzoxaziner til forstærkning af synaptisk(e) reaktion(er) |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6124278A (cs) |
| EP (1) | EP1067935B1 (cs) |
| JP (1) | JP4574846B2 (cs) |
| KR (1) | KR100646753B1 (cs) |
| CN (1) | CN1186020C (cs) |
| AT (1) | ATE247472T1 (cs) |
| BR (1) | BR9909378A (cs) |
| CA (1) | CA2326764C (cs) |
| CZ (1) | CZ292931B6 (cs) |
| DE (1) | DE69910552T2 (cs) |
| DK (1) | DK1067935T3 (cs) |
| ES (1) | ES2207194T3 (cs) |
| HK (1) | HK1039060B (cs) |
| HU (1) | HUP0102321A3 (cs) |
| IL (1) | IL138284A0 (cs) |
| NO (1) | NO20004383L (cs) |
| NZ (1) | NZ506712A (cs) |
| PL (1) | PL195394B1 (cs) |
| PT (1) | PT1067935E (cs) |
| RU (1) | RU2246498C2 (cs) |
| TR (1) | TR200002849T2 (cs) |
| WO (1) | WO1999051240A1 (cs) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI232863B (en) | 2001-06-11 | 2005-05-21 | Akzo Nobel Nv | Benzoxazepine derivatives |
| HRP20031013A2 (hr) | 2001-06-14 | 2005-10-31 | Akzo Nobel N.V. | (PIRIDO/THIENO)-[f]-OXAZEPIN-5-ONE DERIVATIVES |
| UA79940C2 (en) * | 2001-11-26 | 2007-08-10 | Cortex Pharma Inc | Carbonylbenzoxazine compounds for enhancing of glutamatergic synaptic responses |
| US20110104716A1 (en) * | 2003-08-08 | 2011-05-05 | Hasan Mohejeri | Novel method for screening brain-active compounds |
| TW200800959A (en) | 2005-06-10 | 2008-01-01 | Wyeth Corp | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor |
| TW200901974A (en) | 2007-01-16 | 2009-01-16 | Wyeth Corp | Compounds, compositions, and methods of making and using them |
| CA2726554C (en) * | 2008-06-06 | 2015-02-24 | Sanofi-Aventis | Macrocyclic urea and sulfamide derivatives as inhibitors of tafia |
| US20110218190A1 (en) * | 2008-11-10 | 2011-09-08 | The Regents Of The University Of California | Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction |
| JP2016521755A (ja) | 2013-06-13 | 2016-07-25 | ヴェロサイエンス，リミテッド・ライアビリティー・カンパニー | 代謝障害を治療するための組成物および方法 |
| CN108689876B (zh) * | 2018-06-28 | 2020-11-27 | 苏州东南药业股份有限公司 | 一种8-(2-羟基苯甲酰胺基)辛酸钠的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0475908A1 (de) * | 1990-09-14 | 1992-03-18 | Ciba-Geigy Ag | Chromogene Lactamverbindungen und ihre Herstellung und Verwendung |
| NO179912C (no) * | 1990-11-28 | 1997-01-08 | Daiichi Seiyaku Co | Analogifremgangsmåte for fremstilling av et terapeutisk virksomt optisk aktivt pyridobenzoksazinderivat |
| CA2138533C (en) * | 1992-07-24 | 2009-04-14 | Gary S. Lynch | Drugs that enhance synaptic responses mediated by ampa receptors |
| DE4229396C2 (de) * | 1992-09-03 | 1997-06-05 | Glunz Ag | Verfahren zur Herstellung von Span- oder Faserplatten |
| US5650409A (en) * | 1995-06-02 | 1997-07-22 | Cortex Pharmaceuticals, Inc. | Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
| US5736543A (en) * | 1996-04-03 | 1998-04-07 | The Regents Of The University Of California | Benzoxazines for enhancing synaptic response |
| US5985871A (en) * | 1997-12-24 | 1999-11-16 | Cortex Pharmaceuticals, Inc. | Benzoxazine compounds for enhancing synaptic response |
-
1998
- 1998-04-03 US US09/054,916 patent/US6124278A/en not_active Expired - Lifetime
-
1999
- 1999-04-02 DK DK99915240T patent/DK1067935T3/da active
- 1999-04-02 EP EP99915240A patent/EP1067935B1/en not_active Expired - Lifetime
- 1999-04-02 TR TR2000/02849T patent/TR200002849T2/xx unknown
- 1999-04-02 AT AT99915240T patent/ATE247472T1/de active
- 1999-04-02 RU RU2000127738/04A patent/RU2246498C2/ru not_active IP Right Cessation
- 1999-04-02 HU HU0102321A patent/HUP0102321A3/hu unknown
- 1999-04-02 CN CNB998046949A patent/CN1186020C/zh not_active Expired - Fee Related
- 1999-04-02 KR KR1020007010679A patent/KR100646753B1/ko not_active Expired - Fee Related
- 1999-04-02 CA CA2326764A patent/CA2326764C/en not_active Expired - Fee Related
- 1999-04-02 JP JP2000542011A patent/JP4574846B2/ja not_active Expired - Fee Related
- 1999-04-02 CZ CZ20003614A patent/CZ292931B6/cs not_active IP Right Cessation
- 1999-04-02 DE DE69910552T patent/DE69910552T2/de not_active Expired - Lifetime
- 1999-04-02 IL IL13828499A patent/IL138284A0/xx not_active IP Right Cessation
- 1999-04-02 HK HK02100196.0A patent/HK1039060B/zh not_active IP Right Cessation
- 1999-04-02 BR BR9909378-2A patent/BR9909378A/pt not_active Application Discontinuation
- 1999-04-02 PL PL99345687A patent/PL195394B1/pl not_active IP Right Cessation
- 1999-04-02 WO PCT/US1999/007325 patent/WO1999051240A1/en not_active Ceased
- 1999-04-02 ES ES99915240T patent/ES2207194T3/es not_active Expired - Lifetime
- 1999-04-02 PT PT99915240T patent/PT1067935E/pt unknown
- 1999-04-02 NZ NZ506712A patent/NZ506712A/xx unknown
-
2000
- 2000-09-04 NO NO20004383A patent/NO20004383L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0891365T3 (da) | Benzoxaziner til forstærkning af synaptiske responser | |
| PT839134E (pt) | Benzoilpiperidinas/pirrolidinas para melhoramento da resposta sinaptica | |
| CA2138533A1 (en) | Drugs that enhance synaptic responses mediated by ampa receptors | |
| DK1054673T3 (da) | Benzoxazinforbindelser til forstærkelse af synaptisk reaktion | |
| ATE325108T1 (de) | Pyrrolidin-derivate als inhibitoren von cyclischer amp-phosphodiesterase | |
| DK1067935T3 (da) | Acylbenzoxaziner til forstærkning af synaptisk(e) reaktion(er) | |
| NO993768D0 (no) | Benzofuranforbindelser med AMPA reseptor aktivitet | |
| PT1244649E (pt) | Inibidores de fosfodiesterase especificos de mfa ciclica | |
| EA200400584A1 (ru) | Соединения карбонилбензоксазина для усиления глутаматергических синаптических ответов | |
| CA2249654A1 (en) | Benzoxazines for enhancing synaptic response |